Error 404 - Not Found

Suggestions

YouTube Calendar Photos Documents Sites Groups Reader





USATODAY.com - Study says Merck should have pulled Vioxx in 2000 Nov 4, 2004 Drug giant Merck should have pulled its Vioxx painkiller from the market "Our findings indicate that rofecoxib ( Vioxx ) should have been withdrawn independent panel of experts should investigate why manufacturers and

WHAT HAPPENED TO VIOXX USERS? 30, 2004, Merck announced that it was withdrawing Vioxx ® from the For the purposes of this investigation , Thomson Reuters researchers posed are managing their chronic pain and whether additional research should be Use of opiates and other prescription analgesics by former Vioxx users appears to have been

The Vioxx Saga: Perspective on the Recall For those who should have been taking aspirin, i.e. those with history of . 2001 or 2002, the authors concluded that Vioxx should have been withdrawn . a congressional investigation of the way in which the FDA handled the Vioxx matter (1)

Merck & Co., Inc.: Communication Lessons from the Withdrawal of approval in 1999, more than 100 million prescriptions had been written for the the risks of Vioxx , should have caused major concern for Merck and Vioxx users. In a statement made after Finance Committee investigators interviewed the

Vioxx Withdrawal Subject of SEC, Justice Department Probes Nov 8, 2004 Some medical experts are saying that Vioxx should have been withdrawn years ago. According to the British medical journal Lancet, which

Congress to investigate Merck, FDA, and the Vioxx withdrawal Nov 11, 2004 The alarming revelations about Vioxx make me a whole lot more skeptical. after a prior issue with Vioxx and aseptic meningitis, "there had been an with known safety risks to stay on the market longer than it should have ?

Vioxx news and articles Australian courts rule that Vioxx should never have been approved for sale .. investigation into the firm's marketing of the painkiller Vioxx ( withdrawn from the

The Hidden Lesson of the Vioxx Fiasco: Reviving a Hollow FDA funding that it cannot do what Congress – and the public prescription drugs have been out of alignment, leading to overly . Merck's voluntary withdrawal of Vioxx from the market . epidemiologic studies, “ investigators examine the

Rofecoxib - Wikipedia, the free encyclopedia This was largely based on the VIGOR ( Vioxx GI Outcomes Research) study, .. known cardiovascular risk, rofecoxib should have been withdrawn several years earlier. In 2005, Merck retained Debevoise & Plimpton LLP to investigate Vioxx

Vioxx Heart Attack and Stroke Risk - Vioxx Legal News and The withdrawal of Vioxx marks the biggest drug recall in history. FDA for not requiring Merck to do studies investigating heart problems with Vioxx when a " debacle" could have been prevented had the FDA heeded the many warning signs.

Advertising Programs Business Solutions New Privacy & Terms About Google